5 months ago
1
Ozempic, the archetypal GLP-1 RA (semaglutide) therapy, researched and developed by Novo Nordisk is present disposable successful India arsenic 0.25 mg, 0.5 mg and 1 mg successful FlexTouch Pen.
Weekly pricing of Ozempic is 0.25mg for ₹2,200, 0.5mg for ₹2,542 and 1mg for ₹2,794.
Ozempic, a once-weekly injectable formulation of semaglutide—is approved successful India for adults with benignant 2 diabetes arsenic the archetypal enactment treatment, adjunct to fare and exercise.
In it merchandise issued connected Friday the Company said that the Semaglutide was precocious included successful WHO’s Model List of Essential Medicines - highlighting the proven wellness benefits of this innovative attraction for radical surviving with diabetes.
According to the World Health Organisation’s 2023-24 estimates, India has 101 cardinal (roughly 11.4 % of India’s population) radical surviving with diabetes , making it the 2nd largest diabetes-affected populations successful the satellite aft China.
The state besides has 136 cardinal individuals with prediabetes and 254 cardinal radical surviving with generalised obesity, signalling an accelerating wellness situation that requires effective, evidence-based therapies.
“Bringing Ozempic to India is simply a large milestone” said Vikrant Shrotriya - Managing Director, Novo Nordisk India. “Backed by proven objective excellence & satellite people quality, reinforced by a robust proviso chain, Ozempic offers Indian doctors an effectual attraction choice. Our extremity is to supply patients an innovative and accessible therapy that offers improved glycaemic control, meaningful value absorption and semipermanent bosom and kidney extortion – each delivered done a simple, easy-to-use pen device. This once-weekly attraction demonstrates Novo Nordisk’s ongoing committedness to amended wellness outcomes and chronic illness care,” helium added.
